Oryon Cell Therapies vs Supernus Pharmaceuticals
Oryon Cell Therapies vs Supernus Pharmaceuticals, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Oryon Cell Therapies is on 62/100 and Supernus Pharmaceuticals on 60/100.
Where each one leads
Oryon Cell Therapies
Leads on none of the measures we hold for both companies.
Supernus Pharmaceuticals
- agent readiness: 41/100 against 22/100
At a glance
| Measure | Oryon Cell Therapies | Supernus Pharmaceuticals |
|---|---|---|
| What it is | Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders. | Biopharmaceutical company developing and commercializing CNS disease treatments. |
| Category | Biotechnology, Health, Neuroscience, Cell Therapy | Biotechnology, Pharmaceuticals, Healthcare, Neuroscience |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | Not published | 2005 |
| Headquarters | Belmont, USA | Rockville, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Oryon Cell Therapies | Supernus Pharmaceuticals |
|---|---|---|
| Employees | Not published | 809 |
| Total funding | $21.0M | $17.5M |
| Latest round | Series A | Series A |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Oryon Cell Therapies | Supernus Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 60/100 |
| Traction | 38/100 | 56/100 |
| Team | Not published | 30/100 |
| Search visibility | 19/100 | 15/100 |
| Quality | Not published | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (22/100) | D (41/100) |
| Domain ratingLink authority, 0-100 | Not published | 66/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Oryon Cell Therapies | Supernus Pharmaceuticals |
|---|---|---|
| Hosting | Not detected | AWS |
| Frameworks | Not detected | Tailwind CSS, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
Oryon Cell Therapies vs Supernus Pharmaceuticals: common questions
Which is better, Oryon Cell Therapies or Supernus Pharmaceuticals?
On our 0-100 score Oryon Cell Therapies rates higher (62/100 against 60/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Oryon Cell Therapies and Supernus Pharmaceuticals compare on the numbers?
Supernus Pharmaceuticals leads on agent readiness (41/100 against 22/100).
Read the full Oryon Cell Therapies review and pricing or the Supernus Pharmaceuticals review and pricing. You can also browse other Oryon Cell Therapies alternatives we track.